Your browser doesn't support javascript.
loading
Effect of seven anti-tuberculosis treatment regimens on sputum microbiome: a retrospective analysis of the HIGHRIF study 2 and PanACEA MAMS-TB clinical trials.
Musisi, Emmanuel; Wyness, Adam; Eldirdiri, Sahar; Dombay, Evelin; Mtafya, Bariki; Ntinginya, Nyanda E; Heinrich, Norbert; Kibiki, Gibson S; Hoelscher, Michael; Boeree, Martin; Aarnoutse, Rob; Gillespie, Stephen H; Sabiiti, Wilber.
Afiliação
  • Musisi E; Division of Infection and Global Health, School of Medicine, University of St Andrews, St Andrews, UK.
  • Wyness A; Division of Infection and Global Health, School of Medicine, University of St Andrews, St Andrews, UK; Scottish Association of Marine Science, Oban, UK.
  • Eldirdiri S; Department of Microbiology, Kettering General Hospital, Kettering, UK.
  • Dombay E; Division of Infection and Global Health, School of Medicine, University of St Andrews, St Andrews, UK.
  • Mtafya B; Division of Infection and Global Health, School of Medicine, University of St Andrews, St Andrews, UK; National Institute for Medical Research, Mbeya Medical Research Centre, Mbeya, Tanzania.
  • Ntinginya NE; National Institute for Medical Research, Mbeya Medical Research Centre, Mbeya, Tanzania.
  • Heinrich N; Division of Infectious Diseases and Tropical Medicine, University Hospital, University of Munich (LMU), Munich, Germany.
  • Kibiki GS; Kilimanjaro Clinical Research Institute, Moshi, Tanzania; Africa Research Excellence Fund (AREF), London, UK.
  • Hoelscher M; Division of Infectious Diseases and Tropical Medicine, University Hospital, University of Munich (LMU), Munich, Germany; Fraunhofer ITMP, Immunology, Infection and Pandemic Research, Munich, Germany.
  • Boeree M; Department of Lung Diseases, Radboud University Medical Centre, Nijmegen, Netherlands.
  • Aarnoutse R; Department of Pharmacy, Radboud University Medical Centre, Nijmegen, Netherlands.
  • Gillespie SH; Division of Infection and Global Health, School of Medicine, University of St Andrews, St Andrews, UK.
  • Sabiiti W; Division of Infection and Global Health, School of Medicine, University of St Andrews, St Andrews, UK. Electronic address: ws31@st-andrews.ac.uk.
Lancet Microbe ; 4(11): e913-e922, 2023 11.
Article em En | MEDLINE | ID: mdl-37832571
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Tuberculose Pulmonar / Microbiota Limite: Humans País/Região como assunto: Africa Idioma: En Revista: Lancet Microbe Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Tuberculose Pulmonar / Microbiota Limite: Humans País/Região como assunto: Africa Idioma: En Revista: Lancet Microbe Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido